CANDIDÍASE VULVOVAGINAL EM MULHERES INFECTADAS PELO VÍRUS DA IMUNODEFICIÊNCIA HUMANA

Objective: To evaluate the clinical and mycological findings of vulvovaginal candidiasis (VVC) in HIV-infected women. Material and Methods: Prospective study (August 2003 to July 2006) of VVC in women assisted the Department of Special Assistance Maternal-Child HIV/AIDS of University Hospital Lauro Wanderley. The clinical material, obtained by vaginal swabs, was processed (Gram and seeded in CHROMagar Candidaâ) and the yeasts were identified using the classic method. Results: We studied 62 HIV-infected women. The signs and symptoms of VVC presented by 42% different women were (multiple answers): vulvovaginal secretion (84.6%), pruritus (65.4%), burning (34.6%) and/or plates (34.6%). C. albicans (69.2%), C. glabrata (15.4%), C. tropicalis (11.5%) and C. krusei (3.9%) were species identified. Risk factors such as immunologic parameter (CD4), pregnancy and use of TARV was respectively significant (p = 0.006) and not significant (p = 0.787; p = 0,305) with VVC. Conclusion: CVV was common in HIV-infected women, having been observed association with CD4 T counts (≤ 200 cells/mm3). The microbiological characterization and correct diagnosis are important. However, it is advisable to increase the sample size and the introduction of a control group of HIV-uninfected women. DESCRIPTORS: Vulvovaginal candidiasis. Human immunodeficiency virus. Signs and symptoms. Risk factors.